Once daily intravenous (IV) busulfan (Bu) containing preparative regimens for hematopoietic stem cell transplantation (HSCT): Low incidence of Hepatic Veno-Occlusive Disease (HVOD) and improved early survival in a single center’s experience

✍ Scribed by H. Benn; A. Amin; H.-C. Susan; D. Kramek; N. Janbay; D. Randhawa; R. Nath

• Book ID: 116278046
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 63 KB
• Volume: 11
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2004.12.089